Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
Ted Roh, President at SK plasma core Indonesia, shared on LinkedIn:
”A Historic Milestone for Indonesia’s Health Innovation
SKPlasma Core Indonesia, a joint venture between SK plasma, part of Korea’s SK Group, and Indonesia Investment Authority (INA), specializing in the manufacturing of Plasma Derived Medicinal Products (PDMPs), officially launched SK GammaBio and SK Albumin during the National Health Day (HKN) celebration.
This milestone strengthens Indonesia’s health resilience and is made possible through strong collaboration with PMI, Dr. Sardjito Hospital, and continuous support from Kemenkes, BPOM, BKPM, and other national stakeholders.
Indonesia’s need for plasma-derived therapies continues to grow, especially for patients with immunodeficiency disorders, liver disease, severe burns, major trauma, and those in intensive care. Producing these therapies from local donor plasma will enhance supply security, expand access, and improve affordability for Indonesian patients.
We are also honored to receive the “Karya Anak Bangsa” award for national innovation, recognizing SKPlasma Core Indonesia as the pioneer of plasma fractionation in Indonesia.
With our Karawang facility now over 98% complete, we remain committed to advancing pharmaceutical independence and delivering safe, high-quality plasma-derived medicines for Indonesia.
By delivering globally standardized therapies derived from Indonesian donor’s plasma, SKPlasma Core Indonesia reaffirms its dedication to providing safe, high-quality, and sustainable healthcare solutions, while supporting Indonesia’s broader vision of achieving pharmaceutical and healthcare independence.”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
-
Sep 21, 2026, 20:50Rainer Kaiser: Genes and Signalling Pathways Implicated in Procoagulant Platelet Generation
-
Sep 21, 2026, 20:49Natalia Dovlatova: Celebrating Stan Heptinstall and His Legacy in Platelet Science
-
Sep 21, 2026, 20:48Norm Roulet: The Interaction of Pb and SARS-CoV-2 and Its Impact on the Cardiovascular System
-
Sep 21, 2026, 20:45Felix Scholkmann: The Spleen Plays a Key Role in Regulating Platelet Activity
-
Sep 21, 2026, 20:43Claire Pomeroy: Celebrating the 2026 Lasker Awards and Why Medical Research Matters